Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-02

FDA Approved: AMPHOTERICIN B — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an original application for Amphotericin B as a generic drug by Heritage Pharmaceuticals (Avet) to treat serious systemic fungal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphotericin B (Amphotericin B)

Snippet

ORIG AP for AMPHOTERICIN B (AMPHOTERICIN B)